WealthShield Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
WealthShield Partners's PFE Position: Q1 2026 in Review
WealthShield Partners increased its Pfizer (PFE) stake by 9.9% in Q1 2026, buying an estimated $70K and bringing the position to 29,174 shares worth $819K. The position accounts for 0.09% of the portfolio, ranked #204.
WealthShield Partners first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.4M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- WealthShield Partners held 29,174 shares of Pfizer worth $819K as of Q1 2026.
- WealthShield Partners bought 2,629 Pfizer shares in Q1 2026, an estimated $70K.
- Pfizer made up 0.09% of WealthShield Partners's portfolio in Q1 2026, its #204 holding.
- WealthShield Partners first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
- WealthShield Partners's Pfizer position peaked at $1.4M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.